Aurora Cannabis (ACB) Long-Term Deferred Tax (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Long-Term Deferred Tax of $1.8 million for Q1 2026, down 39.04% year-on-year from $2.9 million in Q1 2025, and up 1492.07% on a QoQ basis from $112582.5 in Q4 2025.
Aurora Cannabis (ACB) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Long-Term Deferred Tax for 8 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- Quarterly Long-Term Deferred Tax fell 39.04% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 39.04% YoY) and the FY2026 annual result came in at $1.8 million, down 41.4% from the prior year.
- Long-Term Deferred Tax climbed to $1.8 million in Q1 2026 per ACB's latest filing, from $112582.5 in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for ACB reached as high as $11.4 million in Q3 2023 and fell as low as $7843.4 in Q2 2022.
- A 5-year average of $6.0 million and a median of $4.7 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax soared 145062.13% — and 2025, when it sank 99.23%.
- Year by year, Long-Term Deferred Tax stood at $9.9 million in 2022, then advanced by 11.66% to $11.0 million in 2023, then tumbled by 88.98% to $1.2 million in 2024, then slumped by 90.75% to $112582.5 in 2025, then surged by 1492.07% to $1.8 million in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $1.8 million, $112582.5, and $85742.9 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 112,582.55 |
| Sep 30, 2025 | 85,742.93 |
| Jun 30, 2025 | 3.01 Mn |
| Mar 31, 2025 | 2.94 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 11.07 Mn |
| Jun 30, 2024 | 11.09 Mn |
| Mar 31, 2024 | 4.63 Mn |
| Dec 31, 2023 | 11.04 Mn |
| Sep 30, 2023 | 11.43 Mn |
| Jun 30, 2023 | 11.39 Mn |
| Mar 31, 2023 | 4.83 Mn |
| Dec 31, 2022 | 9.89 Mn |
| Sep 30, 2022 | 11.14 Mn |
| Jun 30, 2022 | 7,843.41 |
| Jun 30, 2021 | 661,397.58 |
| Mar 31, 2019 | 60,907.09 |
| Dec 31, 2018 | 93,944.85 |
| Jun 30, 2018 | 9.04 Mn |